이부프로펜은 비스테로이드성 소염진통제(Non-Steroidal Anti-Inflammatory Drugs; NSAIDs)의 대표적인 성분이다. 이부프로펜은 결정성이 크기 때문에 난용성이며, 따라서 생체이용률(bioavailability)도 낮다. 이와 같은 난용성을 개선하기 위해서는 이부프로펜의 입도를 감소시킬 필요가 있다. 본 연구의 목적은 이부프로펜의 분쇄조건을 최적화하는데 있다. 이부프로펜을 분쇄하기 위하여 유성밀을 사용하였으며, Box-Behnken 방법을 이용하여 분쇄변수들의 최적조건을 구하였다. 이부프로펜 분쇄생성물의 물성을 조사하기 위하여 입도, 결정크기 및 인장강도 측정에는 각각 입도분석기, XRD, tensile/compression tester를 사용하였다. 분쇄 최적조건은 밀회전수는 290 rpm, 시료장입량은 24.6 g, 분쇄시간은 10분이었으며, 이 조건에서 이부프로펜 분쇄생성물의 입도는 13.5 μm이었다. 이부프로펜은 분쇄 후 결정크기가 감소하였다. 이부프로펜 분쇄생성물의 정제의 상대밀도가 0.85~0.90인 범위에서 그 정제의 인장강도는 12~14 Kgf/cm2이었다.

Ibuprofen, non-steroidal anti-inflammatory drugs; NSAIDs, is a highly crystalline substance with the pharmaceutical properties of poor solubility and low bioavailability. The size reduction of ibuprofen is needed to improve the solubility. The objective of this study is to optimize the grinding condition of ibuprofen. Grinding of ibuprofen was carried out using a planetary mill. Grinding parameters were optimized using Box-Behnken experimental design method. The physical characteristics of ground ibuprofen were investigated for the particle size by particle size analyzer, for the crystal size by X-ray diffraction (XRD), and for the tensile strength by tensile/compression tester. The optimum conditions for the milling of ibuprofen were 290 rpm of the revolution number of mill, 24.6 g of the weight of sample, and 10 minutes of grinding time. The measured value of the particle size of ground ibuprofen at these optimum conditions was 13.5μm. The results showed that the crystal size of ibuprofen was reduced by the planetary milling process. In case the relative density of the tablets formulated of ground ibuprofen was range of 0.85~0.90, the tensile strength of them was range of 12~14 Kgf/cm2.

Ibuprofen Optimization Response Surface Methodology Box-behnken Method Grinding

Chaumeil JC, Meth. Find. Exp. Clin.Pharmacol., 20, 211 (1998)
Chiou WL, Riegelman S, J. Pharm. Sci., 60(9), 1281 (1971)
Hancock BC, Zografi G, J.Pharm. Sci., 86, 1 (1997)
Buckton G, Darcy P, Int. J.Pharm., 121, 81 (1995)
Briggner L, Buckton G, Bystrom K, Darcy P, Int. J. Pharm., 105, 125 (1994)
Choi WS, Kim HI, Kwak SS, Chung HY, Chung HY, Yamamoto K, Oguchi T, Tozuka Y, Yonemochi E, Terada K, Int. J. Miner. Process., 74S, S165 (2004)
Chung HY, Yonemochi E, Saitoh T, Terada K, Tozuka Y, Oguchi T, Yamamoto K, Chung HY, Choi WS, Int. J. Pharm., 255, 49 (2003)
Chung HY, Kwak SS, Kim HI, Choi WS, Yakhak Hoeji., 46(2), 102 (2002)
Yonemochi E, Oda K, Saeki S, Oguchi T, Nakai Y, Yamamoto K, Chem. Pharm. Bull., 42, 1948 (1994)
Okonogi S, Yonemochi E, Oguchi T, Puttipiparkhachorn S, Yamamoto K, Drug Dev. Ind. Pharm., 23, 1121 (1997)
Ueno Y, Yonemochi E, Tozuka Y, Yamamura S, Oguchi T, Yamamoto K, J. Pharm. Pharmocol., 50, 1 (1998)
Yonemochi E, Ueno Y, Ohmae T, Oguchi T, Nakajima S, Yamamoto K, Pharm. Res., 14, 802 (1997)
Cho HK, Rhee KY, Paik YN, Transactions of KSME-A., 29(7), 1022 (2005)
Hwang DH, Lee D, Lee H, Choe D, Lee SH, Lee K, Korean J. Chem. Eng., 27(4), 1087 (2010)
Lee K, Lee D, Lee H, Kim CK, Wu Z, Lee K, Korean J. Chem. Eng., 27(4), 1333 (2010)
Rawlinson CF, Williams AC, Timmins P, Grimsey I, Int. J. Pharm., 336, 42 (2007)
Rodriguez R, Alvarez-Lorenzo C, Concheiro A, Eur. J. Pharm. Sci., 20, 429 (2003)
Schiermeier S, Schmidt PC, Eur. J. Pharm. Sci., 15, 295 (2002)
Rasenack N, Steckel H, Muller BW, Powder Technol., 143-144, 291 (2004)
Kayrak D, Akman U, Hortacsu O, J. Supercrit. Fluids, 26(1), 17 (2003)
Mallick S, Pattnaik S, Swain K, De PK, Saha A, Ghoshal G, Mondal A, Eur. J.Pharm. Biopharm., 68, 346 (2008)
Mallick S, Pattnaik S, Swain K, De PK, Saha A, Mazumdar P, Ghoshal G, Drug Dev. Ind. Pharm., 34, 726 (2008)
Lee SH, Data Analysis of Engineering Statistics using Minitab, revision, Iretec Inc., Kunpo, ROK, 647 (2008)
Kim DS, Park YS, J. Korean Soc.Water Qual., 26(1), 35 (2010)
Sim CH, Food Engineering Progress., 15(2), 97 (2011)
Park SH, Design of Experiments, Minyoungsa, Seoul, 453 (2005)
Costa FO, Pais AACC, Sousa JJS, Int.J. Pharm., 270, 9 (2004)
Malvern, Sample Dispersion & Refractive Index Guide, version 3.1, Malvern Instruments Ltd., England, 2.1-2.14 (1997)
Kachrimanis K, Malamataris S, Europeon Journal of Pharmaceutical Sciences., 24, 169 (2005)
Han BH, Han BH, Elements of X-ray Diffraction, Dongmyungsa, Seoul, 231 (2003)
Cullity BD, Stock SR, Elements of X-ray Diffraction, 3 rd ed., Prentice Hall, New Jersey, 167 (2001)
Fell JT, Newton JM, J. Pharm. Sci., 59, 688 (1970)
Shioji Y, Manufacture Technology of Solid Tablet, CMC, Tokyo, Japan, 11-14, 64-66 (2003)
Box GEP, Behnken DW, Technometrics., 2(4), 455 (1960)
Song, R. K., SAS/STAT Regression, 3rd ed., Freedom Academy, Pajoo, 141 (2004)
Sim CH, J. Kor. Pharm. Sci., 38(1), 1 (2008)
Hancock BC, Colvin JT, Mullarnaney MP, Zinchuk AV, Pharm. Technol., 27, 64 (2003)